
IQVIA Hlds (IQV) Stock Forecast & Price Target
IQVIA Hlds (IQV) Analyst Ratings
Bulls say
IQVIA Holdings has demonstrated significant growth across its segments in the third quarter, particularly in Functional Service Provider (FSP), Real World Evidence (RWE), and Customer Sales Management Services (CSMS), all of which showed year-over-year increases. The company is experiencing positive momentum in its commercial operations, driven by enhanced decision-making timelines and a robust pipeline largely influenced by recent drug launches, indicating a strong demand for its services. Furthermore, IQVIA's confidence in achieving a growth rate of over 4% on a constant currency basis ex-COVID underscores the strengthening pricing environment and the strategic decision to walk away from less profitable deals, thereby enhancing its overall financial health.
Bears say
IQVIA Holdings has demonstrated a year-over-year constant currency growth of only 3.8%, a decrease from 6.8% in the previous quarter, indicating potential struggles with maintaining momentum and reflecting challenges from tough year-over-year comparisons. Despite management's assertion that they do not foresee a regression in revenue growth for 2026, there is skepticism surrounding the ability to meet the stated threshold of 5% growth, particularly given margin constraints related to passthroughs and the potential negative impact of rising interest rates on earnings. The disparate organic growth rates across segments, particularly a mere 1.4% in Technology and Analytics Services (TAS), further underscore underlying operational challenges that may hinder overall performance.
This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.
IQVIA Hlds (IQV) Analyst Forecast & Price Prediction
Start investing in IQVIA Hlds (IQV)
Order type
Buy in
Order amount
Est. shares
0 shares